|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:130-136
© 2002 The American Association for Thoracic Surgery
Surgery for Congential Heart Disease |
From the Departments of Cardiothoracic Surgery and Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Supported in part by the Daniel M. Tabas Endowed Chair in Pediatric Cardiothoracic Surgery.
Received for publication April 4, 2001. Revisions requested May 22, 2001; revisions received June 27, 2001. Accepted for publication July 2, 2001. Address for reprints: J. William Gaynor, MD, Cardiothoracic Surgery, Rm 8527, Children's Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104 (E-mail: gaynor{at}email.chop.edu).
Abstract
Objective: Mechanical cardiorespiratory support is occasionally required before or after pediatric thoracic organ transplantation. Extracorporeal membrane oxygenation is the most commonly used mechanical support technique in children. The goal of this study was to examine the indications for initiation and outcomes after peritransplant use of extracorporeal membrane oxygenation.
Methods: A retrospective study was conducted of 65 patients who received peritransplant extracorporeal membrane oxygenation between November 1994 and June 2000. The pretransplant group included 45 patients (average age, 38 months) supported with extracorporeal membrane oxygenation and listed for transplantation (31 heart, 8 lung, and 6 heart-lung), and the post-transplant group included 20 patients (average age, 83 months) who required extracorporeal membrane oxygenation after thoracic organ transplantation (12 heart, 6 lung, and 2 heart-lung transplants). Hospital course and outcomes were evaluated.
Results: With regard to pretransplant extracorporeal membrane oxygenation, patients listed for heart transplants were more likely to survive to transplantation than were those listed for lung or heart-lung transplants (12/31 [39%] vs 1/14 [7%], P = .03). There was no difference in long-term survival between heart transplant patients after extracorporeal membrane oxygenation and those without extracorporeal membrane oxygenation (12-month actuarial survival, 83% vs 73%; P = .68). Patients who survived for prolonged periods on extracorporeal membrane oxygenation (>250 hours) typically received heart transplants (7/8 [88%]). With regard to post-transplant extracorporeal membrane oxygenation, patients receiving lung or heart-lung transplants had better short-term outcomes than those receiving heart transplants (63% survived to discharge vs 33%). All 3 patients with early graft dysfunction receiving lung transplants survived to discharge.
Conclusions: Long-term outcomes among those undergoing heart transplantation after support with an extracorporeal membrane oxygenator are comparable with those of patients not receiving extracorporeal membrane oxygenation. Extracorporeal membrane oxygenation can be a useful post-transplant support device, particularly in patients undergoing lung transplants.
This article has been cited by other articles:
![]() |
Y. Hirata, K. Charette, R. S. Mosca, J. M. Quaegebeur, and J. M. Chen Pediatric Application of the Thoratec CentriMag BiVAD as a Bridge to Heart Transplantation. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1386 - 1387. [Full Text] [PDF] |
||||
![]() |
S. K. Gandhi, C. B. Huddleston, D. T. Balzer, D. J. Epstein, T. A. Boschert, and C. E. Canter Biventricular Assist Devices as a Bridge to Heart Transplantation in Small Children Circulation, September 30, 2008; 118(14_suppl_1): S89 - S93. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martin-Suarez, A. Dell'Amore, R. A. Hopkins, and G. Arpesella Percutaneous circulatory support for myocardial recovery in cardiogenic shock for late acute rejection Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 655 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sharma, S. A. Webber, V. O. Morell, S. K. Gandhi, P. D. Wearden, J. R. Buchanan, and R. L. Kormos Ventricular assist device support in children and adolescents as a bridge to heart transplantation. Ann. Thorac. Surg., September 1, 2006; 82(3): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Padalino, R. G. Ohye, A. C. Chang, R. J. Gajarski, E. L. Bove, and E. J. Devaney Bridge to Transplant Using the MicroMed DeBakey Ventricular Assist Device in a Child with Idiopathic Dilated Cardiomyopathy. Ann. Thorac. Surg., March 1, 2006; 81(3): 1118 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rogers, T. Owens, D. A. Griffin, and T. Frey Extracorporeal membrane oxygenation to cardiopulmonary bypass with a single circuit exposure Perfusion, September 1, 2005; 20(5): 295 - 298. [Abstract] [PDF] |
||||
![]() |
T. Oto, F. Rosenfeldt, M. Rowland, A. Pick, M. Rabinov, A. Preovolos, G. Snell, T. Williams, and D. Esmore Extracorporeal Membrane Oxygenation after Lung Transplantation: Evolving Technique Improves Outcomes Ann. Thorac. Surg., October 1, 2004; 78(4): 1230 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R R Chaturvedi, D Macrae, K L Brown, M Schindler, E C Smith, K B Davis, G Cohen, V Tsang, M Elliott, M de Leval, et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery Heart, May 1, 2004; 90(5): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. McMahon, C. van Doorn, M. Burch, P. Whitmore, S. Neligan, P. Rees, R. Radley-Smith, A. Goldman, K. Brown, G. Cohen, et al. Improved early outcome for end-stage dilated cardiomyopathy in children J. Thorac. Cardiovasc. Surg., January 1, 2004; 126(6): 1781 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Fenton, S. A. Webber, D. A. Danford, S. K. Gandhi, J. Periera, and F. A. Pigula Long-term survival after pediatric cardiac transplantation and postoperative ECMO support Ann. Thorac. Surg., September 1, 2003; 76(3): 843 - 847. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |